Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: "Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+. [NA]

View source ↗

Summary

This is a trial update on the Principle Test to isolate and characterize circulating cancer cells expressing CXCR4. The study, sponsored by the National Cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Neoplasm Malignant | NA | Status: ACTIVE_NOT_RECRUITING